While Reddit tends to skew critical for all GLP-1 clinics, its worth noting the pattern before signing up
For adults over 40: Aim for the higher end
Diabetologia 48(9):17001713 Edwards K, Li X, Lingvay I (2023) Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: a real-world study
and scientific Advisory boards for Eli Lilly, Novo Nordisk, Amgen, Pfizer, Currax, Calibrate, Vida Health, Ilant Health, Mellicell, Sweetch, Doximity, GoodRx, Empros Pharma, Clearmind Medicine, and Apnimed
They are likely multifactorial and may involve delayed gastric emptying, altered intestinal fluid secretion, and central nervous system effects on gut function